JNJ vs CAH
By Alex · Tickerpine
Johnson & Johnson vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CAH |
|---|---|---|
| Price | $260.86 | $234.16 |
| Market cap | $628.65B | $54.46B |
| P/E ratio | 30.3 | 33.2 |
| ROE | 25.74% | — |
| Profit margin | 21.48% | 0.67% |
| Revenue growth | 6.60% | 5.80% |
| Dividend yield | 2.05% | 0.86% |
| Beta | 0.23 | — |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CAH in plain English
- JNJ is the bigger company — about 11.5× the market cap of CAH.
- JNJ is cheaper on earnings (P/E 30.3 vs 33.2).
- JNJ is growing revenue faster (7% vs 6%).
- JNJ has the higher dividend yield (2.05% vs 0.86%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.